Suppr超能文献

肺移植术后 90 天内的有利、艰难或致命的术后途径。

Favorable, arduous or fatal postoperative pathway within 90 days of lung transplantation.

机构信息

Université Paris Cité, AP-HP, Hôpital Bichat Claude Bernard, Anesthésie-Réanimation, Paris, France.

INSERM UMR 1148 LVTS, Université Paris Cité, Paris, France.

出版信息

BMC Pulm Med. 2022 Aug 27;22(1):326. doi: 10.1186/s12890-022-02120-w.

Abstract

INTRODUCTION

The maximum gain in quality of life after lung transplantation (LT) is expected between six months and one year after LT, as the occurrence of chronic lung allograft dysfunction may mask the beneficial effects beyond one year. Thus, the postoperative period could be the cornerstone of graft success. We sought to describe the factors present before postoperative admission to the ICU and associated with favorable, arduous or fatal pathway within 90 days of LT.

MATERIALS AND METHODS

We conducted a retrospective single-center study between January 2015 and December 2020. Using multinomial regression, we assessed the demographic, preoperative and intraoperative characteristics of patients associated with favorable (duration of postoperative mechanical ventilation < 3 days and alive at Day 90), arduous (duration of postoperative mechanical ventilation ≥ 3 days and alive at Day 90) or fatal (dead at Day 90) pathway within 90 days of LT.

RESULTS

A total of 269 lung transplant patients were analyzed. Maximum graft cold ischemic time ≥ 6 h and intraoperative blood transfusion ≥ 3 packed red blood cells were associated with arduous and fatal pathway at Day 90, whereas intraoperative ECMO was strongly associated with fatal pathway.

CONCLUSION

No patient demographics influenced the postoperative pathway at Day 90. Only extrinsic factors involving graft ischemia time, intraoperative transfusion, and intraoperative ECMO determined early postoperative pathway.

摘要

介绍

肺移植(LT)后,生活质量的最大获益预计在 LT 后 6 个月至 1 年内,因为慢性肺移植物功能障碍的发生可能会掩盖 1 年以上的有益影响。因此,术后阶段可能是移植成功的基石。我们旨在描述 ICU 术后入院前存在的、与 LT 后 90 天内有利、艰难或致命途径相关的因素。

材料和方法

我们进行了一项回顾性单中心研究,时间为 2015 年 1 月至 2020 年 12 月。使用多项回归,我们评估了与 LT 后 90 天内有利(术后机械通气持续时间<3 天,第 90 天存活)、艰难(术后机械通气持续时间≥3 天,第 90 天存活)或致命(第 90 天死亡)途径相关的患者的人口统计学、术前和术中特征。

结果

共分析了 269 例肺移植患者。最大移植物冷缺血时间≥6 小时和术中输血≥3 单位红细胞与第 90 天的艰难和致命途径相关,而术中 ECMO 与致命途径密切相关。

结论

没有患者的人口统计学特征影响第 90 天的术后途径。只有涉及移植物缺血时间、术中输血和术中 ECMO 的外在因素决定了术后早期的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fab4/9420258/dd928c824b22/12890_2022_2120_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验